Institutional members access full text with Ovid®

Share this article on:

A Modified ACT Optimized for Monitoring High Levels of Bivalirudin

Zucker, ML; Measday, MA; Koster, A; Sternlicht, A; LaDuca, FM

Abstracts: Abstracts from the 20th International Symposium on Critical Care & Point of Care Testing

Clinical Affairs, ITC, Edison, NJ; Institute Fur Anasthesie, Deutsches Herzzentrum Berlin, Germany; and Medical Affairs, The Medicines Company, Parsippany, NJ.

Editor’s Note: These abstracts were presented at the 20th International Symposium on Critical Care & Point of Care Testing, entitled “The Value of Critical Care and Point of Care Testing: Who Benefits?” Würzburg, Germany. June 9-12, 2004.

© 2004 Lippincott Williams & Wilkins, Inc.